ACLARIS THERAPEUTICS INC (ACRS) Stock Balance Sheet
NASDAQ:ACRS • US00461U1051
Current stock price
3.74 USD
+0.2 (+5.65%)
At close:
3.75 USD
+0.01 (+0.27%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.96M | 24.57M | 39.88M | 45.30M | 27.30M | |||
| Marketable Securities | 70.79M | 89.02M | 79.23M | 172.30M | 164.10M | |||
| Receivables | 5.57M | 318.00K | 298.00K | 500.00K | 600.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | N/A | 12.04M | 9.45M | 13.50M | 13.00M | |||
| Total Current Assets | 96.32M | 125.95M | 128.86M | 231.60M | 205.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.05M | 3.85M | 5.48M | 3.80M | 4.80M | |||
| Investments And Advances | 60.61M | 90.30M | 62.77M | 12.20M | 34.20M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | 269.00K | 7.00M | 7.00M | |||
| Other Non-Current Assets | 486.00K | 224.00K | 30.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 64.14M | 94.38M | 68.55M | 23.00M | 46.20M | |||
| TOTAL ASSETS | 160.46M | 220.33M | 197.41M | 254.60M | 251.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 6.67M | 17.71M | 12.93M | 6.00M | 5.10M | |||
| Accounts Payable | 13.16M | 4.69M | 8.88M | 10.40M | 10.00M | |||
| Other Current Liabilities | 8.81M | 9.19M | 9.15M | 5.60M | 7.90M | |||
| Total Current Liabilities | 28.64M | 31.60M | 30.95M | 21.90M | 22.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 400.00K | 400.00K | |||
| Other Non-Current Liabilities | 28.73M | 33.18M | 9.27M | 34.70M | 30.60M | |||
| Total Non-Current Liabilities | 28.73M | 33.18M | 9.27M | 35.10M | 31.00M | |||
| TOTAL LIABILITIES | 57.38M | 64.77M | 40.23M | 57.00M | 53.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -967.78M | -902.86M | -770.80M | -682.30M | -595.40M | |||
| Additional Paid In Capital | 1.07B | 1.06B | 928.08M | 880.80M | 793.00M | |||
| Common Shares | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 610.00K | 97.00K | -106.00K | -900.00K | -200.00K | |||
| Shares Outstanding | 120.50M | 107.85M | 70.89M | 66.70M | 61.20M | |||
| Tangible Book Value per Share | 0.86 | 1.44 | 2.21 | 2.86 | 3.11 | |||
| Total Shareholders' Equity | 103.08M | 155.55M | 157.18M | 197.60M | 197.30M | |||
| TOTAL LIABILITIES AND EQUITY | 160.46M | 220.33M | 197.41M | 254.60M | 251.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.36 | 3.99 | 4.16 | 10.58 | 8.95 | |||
| Return On Assets (ROA) | -40.46% | -59.94% | -44.82% | -34.14% | -36.17% | |||
| Return On Equity (ROE) | -62.98% | -84.90% | -56.29% | -43.98% | -46.06% | |||
All data in USD , ROIC based on taxRate of 0.21